Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism
NCT00960544
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Principal Investigator departed from institution
Conditions
Breast Cancer
Interventions
DRUG:
Capecitabine
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]